Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2026-04-14 @ 3:02 PM
Study NCT ID:
NCT02255435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-07
First Post:
2014-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-28
Completion Date Type:
ESTIMATED
First Submit Date:
2014-09-30
First Submit QC Date:
None
Study First Post Date:
2014-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-30
Results First Submit QC Date:
None
Results First Post Date:
2022-11-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-10-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-10-07
Last Update Post Date Type:
ESTIMATED